Wells Fargo

Wells Fargo’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Wells Fargo’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$1.96M	Buy
2022 Q4	$157K	Sell
2022 Q3	$414K	Buy
2022 Q2	$79K	Sell
2022 Q1	$325K	Sell
2021 Q4	$812K	Buy
2021 Q3	$367K	Buy
2021 Q2	$2K	Buy